Several methods are being used for the treatment of pericardial effusion (PE) in the pericardiocentesis procedures market. As such, there is a growing awareness about echocardiography (ECHO) as one of the most valuable tools for assessing PE. M-mode ECHO is advantageous to detect even a small amount of fluid accumulated in the pericardium sac around the heart. Thus, advanced medical practices in the pericardiocentesis procedures market are boosting its revenue, which is anticipated to reach a value of ~US$ 230 Mn by the end of 2027.
Tomography and MRI (Magnetic Resonance Imaging) are also emerging as effective tools for the detection of PE. Likewise, CT (Computed Tomography) is being highly publicized as a guiding method in pericardiocentesis procedures. CT also helps in the assessment of postoperative PE. High frequency of localized effusion in postoperative cases has created a demand for CT. As such, CT-guided catheter drainage method is gaining popularity in pericardiocentesis procedures. Healthcare practitioners, especially in cardiac centers are focusing on reduced morbidity and mortality to build their credibility in the market landscape.
Pericardiocentesis procedures are being performed using real-time imaging adjuncts such as transthoracic echocardiography (TTE) or fluoroscopy in order to reduce procedural complications among patients. These procedures are conducted using ECHO machines and require sterile drapes, syringes, needles and local anesthetics, among others. Hence, stakeholders in the pericardiocentesis procedures market are strategizing on increasing their production capacities to increase the availability of equipment and tools that help to overcome any hurdles that healthcare practitioners might come across.
Cardiac indications of hemodynamic instability and cardiac arrest have led to high prevalence of emergency PE cases worldwide. This explains why the revenue of cardiac indications is projected for exponential growth in the pericardiocentesis procedures market. Other prerequisites such as alligator clip connectors and novel nasogastric tubes are being increasingly used to lower the risk of gastric perforation during surgical procedures. Growing awareness about patient positioning and monitoring are bolstering the credibility of cardiologists and surgeons in hospitals.
Currently, the highest number of pericardiocentesis procedures are anticipated to be carried out in North America and Europe by the end of 2020. However, expensive simulations models are posing as a hurdle for learners and practitioners in the market for pericardiocentesis procedures. This explains why the pericardiocentesis procedures market is projected to expand at a modest CAGR of ~4% during the forecast period. Hence, companies are increasing their research in the low-cost and reusable ultrasound pericardiocentesis simulation model, which is transforming the lives of emergency medicine residents and emergency medicine-bound students.
Cardiac tamponade is a time sensitive and life-threatening condition that demands immediate intervention. Though incidence rate of cardiac tamponade among the U.S. population is much less, it is crucial for cardiologists, surgeons, and radiologists to be proficient during the life-saving procedure. Hence, ultrasound-guided pericardiocentesis is generating lucrative opportunities for growth in the pericardiocentesis procedures market.
Companies in the pericardiocentesis procedures market are increasing their efforts in research and education to offer high quality and innovative therapies to patients. They are adopting the multi-disciplinary approach for comprehensive care of patients with pericardial diseases. With the help of state-of-the-art diagnostic testing healthcare providers in the pericardiocentesis procedures market are improving their clinical numbers. In order to improve patient quality of life, cardiologists and clinicians are informing the patients about the possible risks and benefits of pericardiocentesis procedures. In order to further enhance healthcare outcomes, the use of ultrasound or fluoroscopy is highly recommended for lowering the risks of complications during surgical procedures.
ECHO machines are being increasingly used for the diagnosis of PE, and also to determine the severity of the effusion. Other treatment methods such as subxiphoid tube pericardiostomy and anterior thoracotomy with pericardiopleural window opening are generating revenue streams for healthcare providers. Pericardiocentesis procedures are being preferred by individuals after thorough analysis of the patient’s medical history.
Analysts’ Viewpoint
Apart from cardiac applications, the market value share of malignancies is projected to take a leap from ~35% in 2018 to an estimated 38.5% by 2027. Since PE, cardiac tamponade, and other pericardial diseases are some of the life-threatening diseases and demand immediate intervention, there is a surging need for experienced cardiologists and surgeons that help to improve patient outcomes.
Low-cost ultrasound-guided pericardiocentesis is one of the key takeaways that is being highly publicized for making practitioners more proficient in surgical procedures. However, several cardiologists and surgeons lack thorough knowledge about uncorrected coagulopathy and about the anatomy of the chest, thus resulting in complications in patients. Since withdrawal of even small amount of fluid significantly extends the lifetime expectancy of patients by several months and years, companies should increase awareness about patient positioning and monitoring to reduce complications during procedures.
The global pericardiocentesis procedures market was worth US$ 161 Mn and is projected to reach a value of US$ 230 Mn by the end of 2027
Pericardiocentesis procedures market is anticipated to grow at a CAGR of 4% during the forecast period
North America accounted for a major share of the global pericardiocentesis procedures market
Pericardiocentesis procedures market is expected to be driven by high prevalence and increase in incidence rate of malignancy cancer cases and rapidly increasing geriatric population across the globe
Key players in the global pericardiocentesis procedures market include Cleveland Clinic, NewYork-Presbyterian Hospital, The Johns Hopkins Hospital, Saint George Hospital, Buddhist Tzu Chi Medical Foundation, J.W. Goethe University Hospital, The University of Tokyo Hospital, Mediclinic International, and Apollo Hospitals Enterprise Ltd
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Pericardiocentesis Procedures Market
4. Market Overview
4.1. Introduction
4.1.1. Pericardiocentesis Procedures Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Pericardiocentesis Procedures Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Regulatory Scenario
5.2. Overview of Large Pericardial Effusions
5.3. Reimbursement Scenario
5.4. Booming investments in private hospitals in India
6. Global Pericardiocentesis Procedures Market Analysis and Forecast, by Indication
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Indication, 2017–2027
6.3.1. Infections
6.3.1.1. Tuberculosis Infection
6.3.1.2. Bacterial Infection
6.3.1.3. Others
6.3.2. Malignancies
6.3.2.1. Lung Cancer
6.3.2.2. Breast Cancer
6.3.2.3. Lymphoma
6.3.2.4. Others
6.3.3. Inflammatory/Rheumatology
6.3.3.1. Rheumatoid Arthritis
6.3.3.2. Systemic Lupus Erythromatosus
6.3.3.3. Others
6.3.4. Cardiac
6.3.5. Others
6.4. Market Attractiveness Analysis, by Indication
7. Global Pericardiocentesis Procedures Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2017–2027
7.3.1. Hospitals
7.3.2. Cardiac Centers
7.3.3. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global Pericardiocentesis Procedures Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Country/Region
9. North America Global Pericardiocentesis Procedures Market Analysis and Forecast
9.1. Introduction
9.2. Key Findings
9.3. Market Value Forecast, by Indication, 2017–2027
9.3.1. Infections
9.3.1.1. Tuberculosis Infection
9.3.1.2. Bacterial Infection
9.3.1.3. Others
9.3.2. Malignancies
9.3.2.1. Lung Cancer
9.3.2.2. Breast Cancer
9.3.2.3. Lymphoma
9.3.2.4. Others
9.3.3. Inflammatory/Rheumatology
9.3.3.1. Rheumatoid Arthritis
9.3.3.2. Systemic Lupus Erythromatosus
9.3.3.3. Others
9.3.4. Cardiac
9.3.5. Others
9.4. Market Value Forecast, by End-user, 2017–2027
9.4.1. Hospitals
9.4.2. Cardiac Centers
9.4.3. Others
9.5. Market Value Forecast, by Country, 2017–2027
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. By Indication
9.6.2. By End-user
9.6.3. By Country
10. Europe Global Pericardiocentesis Procedures Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Indication, 2017–2027
10.3.1. Infections
10.3.1.1. Tuberculosis Infection
10.3.1.2. Bacterial Infection
10.3.1.3. Others
10.3.2. Malignancies
10.3.2.1. Lung Cancer
10.3.2.2. Breast Cancer
10.3.2.3. Lymphoma
10.3.2.4. Others
10.3.3. Inflammatory/Rheumatology
10.3.3.1. Rheumatoid Arthritis
10.3.3.2. Systemic Lupus Erythromatosus
10.3.3.3. Others
10.3.4. Cardiac
10.3.5. Others
10.4. Market Value Forecast, by End-user, 2017–2027
10.4.1. Hospitals
10.4.2. Cardiac Centers
10.4.3. Others
10.5. Market Value Forecast, by Country/Sub-region, 2017–2027
10.5.1. Germany
10.5.2. U.K.
10.5.3. France
10.5.4. Italy
10.5.5. Spain
10.5.6. Rest of Europe
10.6. Market Attractiveness Analysis
10.6.1. By Indication
10.6.2. By End-user
10.6.3. By Country/Sub-region
11. Asia Pacific Global Pericardiocentesis Procedures Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Indication, 2017–2027
11.3.1. Infections
11.3.1.1. Tuberculosis Infection
11.3.1.2. Bacterial Infection
11.3.1.3. Others
11.3.2. Malignancies
11.3.2.1. Lung Cancer
11.3.2.2. Breast Cancer
11.3.2.3. Lymphoma
11.3.2.4. Others
11.3.3. Inflammatory/Rheumatology
11.3.3.1. Rheumatoid Arthritis
11.3.3.2. Systemic Lupus Erythromatosus
11.3.3.3. Others
11.3.4. Cardiac
11.3.5. Others
11.4. Market Value Forecast, by End-user, 2017–2027
11.4.1. Hospitals
11.4.2. Cardiac Centers
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2027
11.5.1. China
11.5.2. India
11.5.3. Japan
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia Pacific
11.6. Market Attractiveness Analysis
11.6.1. By Technique
11.6.2. By End-user
11.6.3. By Country/Sub-region
12. Latin America Global Pericardiocentesis Procedures Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Indication, 2017–2027
12.3.1. Infections
12.3.1.1. Tuberculosis Infection
12.3.1.2. Bacterial Infection
12.3.1.3. Others
12.3.2. Malignancies
12.3.2.1. Lung Cancer
12.3.2.2. Breast Cancer
12.3.2.3. Lymphoma
12.3.2.4. Others
12.3.3. Inflammatory/Rheumatology
12.3.3.1. Rheumatoid Arthritis
12.3.3.2. Systemic Lupus Erythromatosus
12.3.3.3. Others
12.3.4. Cardiac
12.3.5. Others
12.4. Market Value Forecast, by End-user, 2017–2027
12.4.1. Hospitals
12.4.2. Cardiac Centers
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2027
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Market Attractiveness Analysis
12.6.1. By Technique
12.6.2. By End-user
12.6.3. By Country/Sub-region
13. Middle East and Africa Global Pericardiocentesis Procedures Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Indication, 2017–2027
13.3.1. Infections
13.3.1.1. Tuberculosis Infection
13.3.1.2. Bacterial Infection
13.3.1.3. Others
13.3.2. Malignancies
13.3.2.1. Lung Cancer
13.3.2.2. Breast Cancer
13.3.2.3. Lymphoma
13.3.2.4. Others
13.3.3. Inflammatory/Rheumatology
13.3.3.1. Rheumatoid Arthritis
13.3.3.2. Systemic Lupus Erythromatosus
13.3.3.3. Others
13.3.4. Cardiac
13.3.5. Others
13.4. Market Value Forecast, by End-user, 2017–2027
13.4.1. Hospitals
13.4.2. Cardiac Centers
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2027
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of Middle East & Africa
13.6. Market Attractiveness Analysis
13.6.1. By Technique
13.6.2. By End-user
13.6.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competition Matrix (By Tier and Size of companies)
14.2. Market Share Analysis, by Company, 2018
14.3. Company Profiles
14.3.1. New York-Presbyterian Hospital/Weill Cornell Medical Center
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Strategic Overview
14.3.2. Florida Hospital Orlando
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Strategic Overview
14.3.3. Cleveland Clinic
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Strategic Overview
14.3.4. John Hopkins Hospital
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Strategic Overview
14.3.5. Saint George Hospital
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Strategic Overview
14.3.6. Buddhist Tzu Chi General Hospital
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Strategic Overview
14.3.7. J. W. Goethe University Hospital
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Product Portfolio
14.3.7.3. SWOT Analysis
14.3.7.4. Strategic Overview
14.3.8. The University of Tokyo Hospital
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Product Portfolio
14.3.8.3. SWOT Analysis
14.3.8.4. Strategic Overview
14.3.9. Heart Institute, University of Sao Paulo
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Product Portfolio
14.3.9.3. SWOT Analysis
14.3.9.4. Strategic Overview
14.3.10. Mediclinic International
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Product Portfolio
14.3.10.3. SWOT Analysis
14.3.10.4. Strategic Overview
14.3.11. Apollo Hospitals Enterprise Ltd
14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.11.2. Product Portfolio
14.3.11.3. SWOT Analysis
14.3.11.4. Strategic Overview
List of Tables
Table 01: Global Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 02: Global Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Infections, 2017–2027
Table 03: Global Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Malignancies, 2017–2027
Table 04: Global Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Inflammatory/Rheumatologic, 2017–2027
Table 05: Global Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 06: Global Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 07: Global Pericardiocentesis Procedures Market Volume (Number of Procedures) Forecast, by Region, 2017–2027
Table 08: North America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 09: North America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 10: North America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Infections, 2017–2027
Table 11: North America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Malignancies, 2017–2027
Table 12: North America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Inflammatory/Rheumatologic, 2017–2027
Table 13: North America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 14: Europe Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 15: Europe Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 16: Europe Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Infections, 2017–2027
Table 17: Europe Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Malignancies, 2017–2027
Table 18: Europe Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Inflammatory/Rheumatologic, 2017–2027
Table 19: Europe Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 20: Asia Pacific Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 21: Asia Pacific Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 22: Asia Pacific Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Infections, 2017–2027
Table 23: Asia Pacific Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Malignancies, 2017–2027
Table 24: Asia Pacific Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Inflammatory/Rheumatologic, 2017–2027
Table 25: Asia Pacific Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 26: Latin America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 27: Latin America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 28: Latin America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Infections, 2017–2027
Table 29: Latin America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Malignancies, 2017–2027
Table 30: Latin America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Inflammatory/Rheumatologic, 2017–2027
Table 31: Latin America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 32: Middle East & Africa Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 33: Middle East & Africa Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 34: Middle East & Africa Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Infections, 2017–2027
Table 35: Middle East & Africa Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Malignancies, 2017–2027
Table 36: Middle East & Africa Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Inflammatory/Rheumatologic, 2017–2027
Table 37: Middle East & Africa Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by End-user, 2017–2027
List of Figures
Figure 01: Global Pericardiocentesis Procedures Market Value (US$ Mn) and Distribution (%), by Region, 2018 and 2027
Figure 02: Global Pericardiocentesis Market Value (US$ Mn) and Volume (Number of Procedures) Forecast, 2017–2027
Figure 03: Global Pericardiocentesis Procedures Market Value Share, by Indication, 2018
Figure 04: Global Pericardiocentesis Procedures Market Value Share, by End-user, 2018
Figure 05: Global Pericardiocentesis Procedures Market Value Share, by Region, 2018
Figure 06: Global Pericardiocentesis Procedures Market Value Share Analysis, by Indication, 2018 and 2027
Figure 07: Global Pericardiocentesis Procedures Market Value (US$ Mn) and Y-o-Y Growth, by Infections, 2017–2027
Figure 08: Global Pericardiocentesis Procedures Market Value (US$ Mn) and Y-o-Y Growth, by Malignancies, 2017–2027
Figure 09: Global Pericardiocentesis Procedures Market Value (US$ Mn) and Y-o-Y Growth, by Inflammatory/ Rheumatologic, 2017–2027
Figure 10: Global Pericardiocentesis Procedures Market Value (US$ Mn) and Y-o-Y Growth, by Cardiac, 2017–2027
Figure 11: Global Pericardiocentesis Procedures Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2027
Figure 12: Global Pericardiocentesis Procedures Market Attractiveness Analysis, by Indication, 2019–2027
Figure 13: Global Pericardiocentesis Procedures Market Value Share Analysis, by End-user, 2018 and 2027
Figure 14: Global Pericardiocentesis Procedures Market Attractiveness Analysis, by End-user, 2019–2027
Figure 15: Global Pericardiocentesis Procedures Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017–2027
Figure 16: Global Pericardiocentesis Procedures Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cardiac Centers, 2017–2027
Figure 17: Global Pericardiocentesis Procedures Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027
Figure 18: Global Pericardiocentesis Procedures Market Value Share Analysis, by Region, 2018 and 2027
Figure 19: Global Pericardiocentesis Procedures Market Attractiveness Analysis, by Region, 2019–2027
Figure 20: North America Pericardiocentesis Procedures Market Value (US$ Mn) and Volume (Number of Procedures) Forecast, 2017–2027
Figure 21: North America Pericardiocentesis Procedures Market Value Share Analysis, by Country, 2018 and 2027
Figure 22: North America Pericardiocentesis Procedures Market Attractiveness, by Country, 2019–2027
Figure 23: North America Pericardiocentesis Procedures Market Value Share Analysis, by Indication, 2018 and 2027
Figure 24: North America Pericardiocentesis Procedures Market Attractiveness Analysis, by Indication, 2019–2027
Figure 25: North America Pericardiocentesis Procedures Market Value Share Analysis, by End-user, 2018 and 2027
Figure 26: North America Pericardiocentesis Procedures Market Attractiveness Analysis, by End-user, 2019–2027
Figure 27: Europe Pericardiocentesis Procedures Market Value (US$ Mn) and Volume (Number of Procedure) Forecast, 2017–2027
Figure 28: Europe Pericardiocentesis Procedures Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 29: Europe Pericardiocentesis Procedures Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 30: Europe Pericardiocentesis Procedures Market Value Share Analysis, by Indication, 2018 and 2027
Figure 31: Europe Pericardiocentesis Procedures Market Attractiveness Analysis, by Indication, 2019–2027
Figure 32: Europe Pericardiocentesis Procedures Market Value Share Analysis, by End-user, 2018 and 2027
Figure 33: Europe Pericardiocentesis Procedures Market Attractiveness Analysis, by End-user, 2019–2027
Figure 34: Asia Pacific Pericardiocentesis Procedures Market Value (US$ Mn) and Volume (Number of Procedures) Forecast, 2017–2027
Figure 35: Asia Pacific Pericardiocentesis Procedures Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 36: Asia Pacific Pericardiocentesis Procedures Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 37: Asia Pacific Pericardiocentesis Procedures Market Value Share Analysis, by Indication, 2018 and 2027
Figure 38: Asia Pacific Pericardiocentesis Procedures Market Attractiveness Analysis, by Indication, 2019–2027
Figure 39: Asia Pacific Pericardiocentesis Procedures Market Value Share Analysis, by End-user, 2018 and 2027
Figure 40: Asia Pacific Pericardiocentesis Procedures Market Attractiveness Analysis, by End-user, 2019–2027
Figure 41: Latin America Pericardiocentesis Procedures Market Value (US$ Mn) and Volume (Number of procedures) Forecast, 2017–2027
Figure 42: Latin America Pericardiocentesis Procedures Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 43: Latin America Pericardiocentesis Procedures Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 44: Latin America Pericardiocentesis Procedures Market Value Share Analysis, by Indication, 2018 and 2027
Figure 45: Latin America Pericardiocentesis Procedures Market Attractiveness Analysis, by Indication, 2019–2027
Figure 46: Latin America Pericardiocentesis Procedures Market Value Share Analysis, by End-user, 2018 and 2027
Figure 47: Latin America Pericardiocentesis Procedures Market Attractiveness Analysis, by End-user, 2019–2027
Figure 48: Middle East & Africa Pericardiocentesis Procedures Market Value (US$ Mn) and Volume (Number of procedures) Forecast, 2017–2027
Figure 49: Middle East & Africa Pericardiocentesis Procedures Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 50: Middle East & Africa Pericardiocentesis Procedures Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 51: Middle East & Africa Pericardiocentesis Procedures Market Value Share Analysis, by Indication, 2018 and 2027
Figure 52: Middle East & Africa Pericardiocentesis Procedures Market Attractiveness Analysis, by Indication, 2019–2027
Figure 53: Middle East & Africa Pericardiocentesis Procedures Market Value Share Analysis, by End-user, 2018 and 2027
Figure 54: Middle East & Africa Pericardiocentesis Procedures Market Attractiveness Analysis, by End-user, 2019–2027
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Pericardiocentesis Procedures Market
